<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03160677</url>
  </required_header>
  <id_info>
    <org_study_id>MMI_2016_26</org_study_id>
    <nct_id>NCT03160677</nct_id>
  </id_info>
  <brief_title>Blood Pressure Target in Acute Stroke to Reduce hemorrhaGe After Endovascular Therapy</brief_title>
  <acronym>BP-TARGET</acronym>
  <official_title>Comparison of Two Strategies for Blood Pressure Control in the Setting of Acute Ischemic Stroke to Reduce Cerebral Hemorrhage After Thrombectomy: Systolic Blood Pressure Target of Less Than 130 mmHg vs Less Than 185 mmHg, for 24 Hours Following Reperfusion, in Patients With Cerebral Infarction Due to Occlusion of the Anterior Circulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized, multicenter study comparing two strategies: 1 / standard management of systolic
      blood pressure according to international recommendations (systolic blood pressure &lt;185 mm
      Hg) versus 2 / intensive blood pressure management Systolic with a target &lt;130 mm Hg.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be followed for 3 months:

        -  inclusion after reperfusion: clinical evaluation with NIHSS (National Institute of
           Health Stroke Score) score, measurement of blood pressure.

        -  within 24 hours after reperfusion: blood pressure measurements

        -  at 24 hours: measurement of blood pressure (T0 + 24 h and evaluation of the NIHSS score.

        -  Between 24 and 36 hours :cerebral scan (assessment of hemorrhagic transformations and
           cerebral infarction volumes). For some centers: Cerebral MRI without injection between
           H24 and H36

        -  72 hours after reperfusion: Cerebral scanner in case of hyperdensity on the initial
           scanner

        -  3 months after reperfusion: disability assessment by Rankin score
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 21, 2017</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of patients with intracranial hemorrhagic complications</measure>
    <time_frame>Scan performed between 24 and 36 hours after thrombectomy</time_frame>
    <description>Rate of patients with intracranial hemorrhagic complications (Symptomatic or asymptomatic) on cerebral scan, evaluated with a double centralized blind reading</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Acute Stroke</condition>
  <condition>Blood Pressure</condition>
  <condition>Cerebral Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Intensive blood pressure management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard blood pressure management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Systolic blood pressure target &lt; 130 mm Hg</intervention_name>
    <description>Adaptation of antihypertensive treatments to reach the Systolic blood pressure target &lt; 130 mm Hg</description>
    <arm_group_label>Intensive blood pressure management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Systolic blood pressure target &lt; 185 mm Hg</intervention_name>
    <description>Adaptation of antihypertensive treatments to reach the Systolic blood pressure target &lt; 185 mm Hg</description>
    <arm_group_label>Standard blood pressure management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Intracranial Occlusion of internal carotid arteries and/or proximal middle cerebral
             (segment M1) diagnosis made on initial Imaging.

          -  Reperfusion after a thrombectomy procedure (defined by a 2b-3 TICI score -Thrombolysis
             In Cerebral Infarction- score).

        Exclusion Criteria:

          -  Per-procedure hemorrhagic complications (prior to reperfusion)

          -  Systolic blood pressure at baseline &lt;130 mm Hg within one hour of recanalization

          -  Pre-existing stroke handicap defined by a Rankin score (modified scale, mRS)&gt; 3

          -  Hemodynamically significant carotid stenosis

          -  Occlusion of the isolated cervical carotid artery

          -  Known pregnancy

          -  Legal protection

          -  Non-affiliation to a social security scheme

          -  Refusal of the patient (or of his / her relatives in case of urgent inclusion)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mikael MAZIGHI, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation Ophtalmologique A. de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence SALOMON, MD PhD</last_name>
    <phone>01.48.03.64.31</phone>
    <phone_ext>+33</phone_ext>
    <email>lsalomon@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Igor SIBON</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital neurologique Pierre Wertheimer, Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francis TURJMAN</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Régional Universitaire</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sébastien RICHARD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondation Ophtalmologique A de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mikael MAZIGHI, MD PhD</last_name>
      <email>mmazighi@for.paris</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand LAPERGUE</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2017</study_first_submitted>
  <study_first_submitted_qc>May 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2017</study_first_posted>
  <last_update_submitted>January 31, 2018</last_update_submitted>
  <last_update_submitted_qc>January 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Stroke</keyword>
  <keyword>Blood Pressure</keyword>
  <keyword>Cerebral Hemorrhage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Cerebral Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

